Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Marta Fiocco

Statistician
  • Biobank & Clinical Research Committee
--
Phone 088 97 25 206

--

  • Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma – a multi-center study

    • dec. 2025
    • Nina U., Gelineau, et al
    • Journal of Experimental and Clinical Cancer Research
  • The latency time of SARS-CoV- 2 Delta variant in infection- and vaccine-naive individuals from Vietnam

    • dec. 2025
    • Vera H., Arntzen, et al
    • BMC Infectious Diseases
  • Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas

    • dec. 2025
    • , et al
    • BMC Medical Informatics and Decision Making
  • Summary measures in non-inferiority clinical trials with a time-to-event outcome

    • dec. 2025
    • S. D.Lana, Broer, et al
    • BMC Medical Research Methodology
  • Modified OPTIModel with oligometastatic disease for the prediction of overall survival of patients with renal cell cancer and symptomatic long bone metastases

    • dec. 2025
    • E. W., Dootjes, et al
    • Journal of Bone Oncology
View all publications